Stock Markets March 10, 2026 10:31 AM

Broad Market Movers: Micron, NIO Rally as BioNTech and Palantir Slip

A cross-cap snapshot of large daily swings, from mega-caps to small-cap listings

By Maya Rios MU BABA CSCO PLTR BNTX

Tuesday’s session featured notable price moves across market-cap tiers. Semiconductor names and select automakers climbed, while several biotechnology and data analytics stocks declined. The lists below capture the largest percentage changes reported across mega-cap, large-cap, mid-cap and small-cap groups.

Broad Market Movers: Micron, NIO Rally as BioNTech and Palantir Slip
MU BABA CSCO PLTR BNTX

Key Points

  • Semiconductor and select technology names, including Micron Tech (MU) and Cisco (CSCO), posted gains in the mega-cap category.
  • Automotive-related stocks like NIO (NIO) and Rivian (RIVN) advanced following analyst activity and demand commentary.
  • Biotechnology and some software firms experienced notable declines, led by BioNTech (BNTX) and Palantir (PLTR).

Stocks showed divergent performance on Tuesday as investors reacted to company-specific updates and analyst activity. Several technology and automotive names advanced, while some healthcare and software-related companies posted declines. The movements spanned from the largest market-capitalization names down to small-cap issuers.


Mega-Cap Movers ($200B+ Market Cap)

  • Micron Tech (MU) +5.46%
  • Alibaba-exch (BABA) +3.04%
  • Cisco Sys Inc (CSCO) +2.8%
  • Palantir Technologies Inc (PLTR) -3.04%

Large-Cap Stock Movers ($10B-$200B Market Cap)

  • Biontech Se (BNTX); BioNTech tumbles over 19% on fourth quarter earnings miss -20.55%
  • Centene (CNC) -10.28%
  • NIO Inc (NIO) +9.94%
  • Rivian Automotive (RIVN); TD Cowen upgrades Rivian stock rating on R2 demand outlook +8.82%
  • Vertex Pharm (VRTX); Jefferies initiates Gilead Sciences stock with buy rating +8.8%
  • Lumentum Holdings Inc (LITE) +7.26%
  • Ciena (CIEN) +6.53%
  • Coherent (COHR) +5.29%
  • HubSpot Inc (HUBS) -6.93%
  • Fair Isaac and Comp Inc (FICO) -6.69%

Mid-Cap Stock Movers ($2B-$10B Market Cap)

  • AXT Inc (AXTI) +17.88%
  • Applied Opt (AAOI) +9.02%
  • Dynergy (DYN) +11.96%
  • 21Vianet Group (VNET) +10.21%
  • Mudrick Capital A (HYMC) +10.28%
  • SolarEdge Technologies Inc (SEDG) +8.27%
  • Oaktree Acquisition Corp (HIMS); Needham upgrades Hims and Hers stock rating on Novo partnership +8.39%
  • Crispr Therapeutics AG (CRSP); CRISPR Therapeutics plans $350M convertible notes offering -7.18%
  • United Natural Foods (UNFI); United Natural Foods beats earnings but revenue falls short -7.05%
  • Fly Leasing Ltd (FLY) -7.81%

Small-Cap Stock Movers ($300M-$2B Market Cap)

  • KemPharm Inc (ZVRA) +20.29%
  • MDC Partners Inc (STGW); Stagwell partners with AppLovin for mobile ad platform access +20.04%
  • Oxygen Biotherape (TENX) +17.97%
  • Capricor Therap (CAPR); FDA resumes review of Capricor’s Deramiocel for DMD treatment +17.53%
  • Vanda Pharmaceuticals (VNDA) +13.02%
  • National Research Corporation (NRC); NRC Health authorizes $60 million stock buyback program +12.59%
  • Unusual Machines (UMAC) +11.14%
  • W&T Offshore Inc (WTI) -14.08%
  • Mesa Laboratories (MLAB); Mesa Labs names Dr. Siddhartha Kadia as new CEO -15.67%
  • Bleichroeder Acquisition I (BACQ) -21.9%

These lists reflect the largest percentage gains and losses reported in the session across market-cap groupings. The moves include a mix of analyst-driven upgrades, corporate developments, and earnings-related reactions as noted alongside several tickers.

The article is a snapshot of day-to-day market action, cataloging prominent winners and losers without evaluating longer-term implications.

Risks

  • Earnings misses or disappointing quarterly results can produce sharp declines, as illustrated by BioNTech's -20.55% move, affecting the biotechnology sector.
  • Analyst rating changes and deal announcements can drive volatile swings in stock prices, which bears on technology and automotive-related equities.
  • Convertible note offerings and financing actions, such as CRISPR Therapeutics planning a $350 million convertible notes offering, may introduce dilution or financing risk for mid-cap biotech issuers.

More from Stock Markets

Red Cat Holdings Sees After-Hours Slide Following $200 Million Equity Offering Announcement May 12, 2026 FCC Signs Off on EchoStar’s $40 Billion Spectrum Sale to SpaceX and AT&T May 12, 2026 CFPB Leadership Moving to Bring Staff Back to Office After Year-Long Closure May 12, 2026 TrueBlue Shares Rise After HireQuest Offers $105M for PeopleReady On-Demand Unit May 12, 2026 U.S. Equities Finish Mixed as Healthcare, Telecoms and Energy Outperform; Tech and Industrials Slip May 12, 2026